Literature DB >> 3095366

Improved biochemical screening procedure for small clinical laboratories for vero (Shiga-like)-toxin-producing strains of Escherichia coli O157:H7.

D J Haldane, M A Damm, J D Anderson.   

Abstract

Of 327 sorbitol-negative fecal isolates of Escherichia coli, 37 O157:H7 Vero (Shiga-like)-toxin-producing strains were identified. The specificity of the basic sorbitol screen was improved from 11.3 to 33.6% by the exclusion of organisms with negative ornithine and lysine decarboxylase reactions.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3095366      PMCID： PMC268993          DOI： 10.1128/jcm.24.4.652-653.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada.

Authors:  W M Johnson; H Lior; G S Bezanson
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

2.  Haemorrhagic cystitis and balanitis associated with verotoxin-producing Escherichia coli O157:H7.

Authors:  W R Grandsen; M A Damm; J D Anderson; J E Carter; H Lior
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

3.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

Review 4.  Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis.

Authors:  M M Levine; R Edelman
Journal:  Epidemiol Rev       Date:  1984       Impact factor: 6.222

5.  H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis.

Authors:  J J Farmer; B R Davis
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

6.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

8.  Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups.

Authors:  T G Cleary; J J Mathewson; E Faris; L K Pickering
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948
  10 in total
  13 in total

1.  Particular biochemical profiles for enterohemorrhagic Escherichia coli O157:H7 isolates on the ID 32E system.

Authors:  A Leclercq; B Lambert; D Pierard; J Mahillon
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157.

Authors:  H Kleanthous; N K Fry; H R Smith; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

3.  Haemorrhagic colitis: detection of verotoxin producing Escherichia coli O157 in a clinical microbiology laboratory.

Authors:  C W Walker; R Upson; R E Warren
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

4.  Inhibition of Escherichia coli serotype O157:H7 by bromthymol blue.

Authors:  S M Gubash; C M Anand; M Stokman
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

5.  The isolation rate of Escherichia coli 0157:H7 in Toronto and surrounding communities.

Authors:  A E Simor; C Watt; D E Low
Journal:  Can J Infect Dis       Date:  1990

6.  Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome.

Authors:  F Gunzer; H Böhm; H Rüssmann; M Bitzan; S Aleksic; H Karch
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

7.  Virulence factors and phenotypical traits of verotoxigenic strains of Escherichia coli isolated from human patients in Germany.

Authors:  L Beutin; S Aleksic; S Zimmermann; K Gleier
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

8.  Detection of Shiga toxin-producing Shigella dysenteriae type 1 and Escherichia coli by using polymerase chain reaction with incorporation of digoxigenin-11-dUTP.

Authors:  M P Jackson
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

9.  Two-hour miniaturized system for detection of enteropathogenic bacteria in stool cultures.

Authors:  A von Graevenitz; J Zollinger-Iten; D Monget
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

10.  Nissui glucose fermentative gram-negative rod identification system EB-20 gives a unique profile for typical non-sorbitol-fermenting Escherichia coli O157:H7.

Authors:  H Kodaka; Y Uesaka; F Kashitani
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.